Jun 30, 2026 07:30AM
Mar 30, 2022 04:05PM
May 13, 2021 04:05PM
Mar 16, 2021 09:30AM
Mar 15, 2021 09:29AM
Mar 12, 2020 04:05PM
Dec 30, 2019 08:05AM Savara (SVRA) Granted Breakthrough Therapy Designation for Molgradex for Treatment of aPAP
Dec 30, 2019 08:05AM
Dec 20, 2019 11:53AM
Dec 20, 2019 11:51AM
Dec 3, 2019 04:12PM
Dec 3, 2019 04:05PM
Nov 18, 2019 08:05AM
Nov 7, 2019 04:05PM Savara Reports Third Quarter 2019 Financial Results and Provides Business Update
Oct 2, 2019 09:19AM
Oct 2, 2019 08:08AM
Oct 2, 2019 08:02AM
Sep 18, 2019 04:15PM
Aug 8, 2019 04:02PM
Aug 1, 2019 08:02AM
Jul 31, 2019 08:02AM Savara to Present at the 39th Annual Canaccord Genuity Global Growth Conference
Jun 13, 2019 04:02PM
Jun 12, 2019 04:04PM
Jun 12, 2019 04:02PM
May 9, 2019 04:02PM
May 6, 2019 08:11AM
May 6, 2019 08:02AM
May 2, 2019 08:02AM Savara to Report First Quarter 2019 Financial Results and Provide Business Update
Apr 2, 2019 08:00AM
Apr 1, 2019 08:12AM
Apr 1, 2019 08:00AM
Mar 13, 2019 04:02PM
Mar 6, 2019 08:00AM
Mar 4, 2019 08:00AM
Feb 6, 2019 08:06AM Savara (SVRA) Provides Update on IMPALA and AVAIL Pivotal Clinical Studies
Feb 6, 2019 08:00AM
Feb 6, 2019 08:00AM
Dec 19, 2018 08:03AM
Dec 19, 2018 08:00AM
Dec 19, 2018 08:00AM
Nov 16, 2018 08:00AM
Nov 16, 2018 08:00AM Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th
Nov 7, 2018 04:02PM
Nov 7, 2018 04:02PM
Nov 1, 2018 08:00AM
Nov 1, 2018 08:00AM
Oct 31, 2018 08:06AM
Oct 31, 2018 08:00AM
Oct 31, 2018 08:00AM Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM
Oct 15, 2018 08:02AM

1,163,953 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All